However, recent studies have demonstrated that a relatively large number of CIS cases showed wild-type expression patterns of p53 (approximately 30–60% of CIS in the previous reports and 45.3% of the present cohort) [35,54]. This evidence concerns the gene TP53 and in situ carcinoma.